
| Serial Number | 79385969 |
| Word Mark | IQIRVO |
| Filing Date | Thursday, October 5, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 22, 2024 |
| Registration Number | 7540092 |
| Registration Date | Tuesday, October 22, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 6, 2024 |
| Description of Mark | The mark consists of the stylized wording "IQIRVO" with the letters "IQIR" and "O" in purple and the letter "V" formed by three blue parallel lines with a purple shadow in the lower left portion. |
| Goods and Services | Pharmaceutical and veterinary products, namely, pharmaceutical and veterinary preparations for prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, immune disorders and cancers; chemical preparations for medical or pharmaceutical use, namely, chemical reagents for medical or pharmaceutical use, diagnostic preparations for medical use, diagnostic testing agents and substances for medical use |
| Indication of Colors claimed | The color(s) purple and blue is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 17, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GENFIT |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Party Name | GENFIT |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Party Name | GENFIT |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Tuesday, January 2, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, December 21, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, January 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 24, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, May 29, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, June 14, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, June 26, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, June 26, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, June 28, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 28, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 28, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, July 15, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, July 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 6, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 22, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 22, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Saturday, March 29, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, March 29, 2025 | FINAL DISPOSITION PROCESSED |
| Saturday, April 19, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, January 22, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 20, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, May 20, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Friday, June 27, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, June 19, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |